deCODE Genetics Announces Webcast of Presentation
News Feb 07, 2006
deCODE genetics has announced that its presentation at Nasdaq’s U.S. Small Cap Conference will be webcast live. deCODE CEO Dr. Kari Stefansson will provide an overview of the company’s drug development programs and business.
The presentation will be delivered at 10am GMT/5am EST on Wednesday, February 8, 2006, at the Merrill Lynch Financial Centre in London.
The webcast will be archived for at least one week on both sites. Those interested in listening should log on a few minutes in advance, in order to download any software or complete any sign-in that may be required.
In treating inflammatory bowel disease (IBD), physicians can have a hard time telling which newly diagnosed patients have a high risk of severe inflammation or what therapies will be most effective. Now researchers report finding an epigenetic signature in patient cells that appears to predict inflammation risk in a serious type of IBD called Crohn’s disease.